Whereas the CRISPR/Cas technology cuts out a defect in a gene and replaces it with a new piece, the latest CRISPR technology works differently. The goal is to repair the error in the DNA without cutting it.
A group of researchers at the University at Buffalo have published a paper that clarifies certain cellular mechanisms that could lead to improved outcomes in patients with globoid cell leukodystrophy, commonly known as Krabbe disease.
The reconstitution of the blood system in humans holds great therapeutic potential to treat many disorders, like blood cancers, sickle-cell anemia and others. Successful reconstitution requires the transplantation and engraftment of hematopoietic (or blood) stem cells (HSCs), which after reaching their niche, start producing all types of blood cells, including platelets, white and red blood cells.
ARCoV, a novel coronavirus Messenger RNA (mRNA) vaccine candidate jointly developed by the People's Liberation Army (PLA) Academy of Military Sciences, Suzhou Abogen Biosciences and Walvax Biotechnology Co., Ltd, was officially approved by the National Medical Products Administration of clinical trial on June 19, according to CCTV's report.
Stem cells and regenerative medicine are among the novel areas in the world, and many efforts have been made to improve the field. New phenomena have occurred in the country by the efforts of activists in the innovation and technology ecosystem along with global attempts. Iran has advanced significantly in this field and has dedicated efforts to reaching the tenth rank in the world.
Iran ranks 15th in the world in the production of scientific articles/The End of the Superiority of the United States and the First Rank of China99/04/24
According to the latest data of the Scopus Database in 2019 in Iran, the number of scientific article publication of Iran improved by one step. Today, Iran is ranked 15th in the world, which has been the highest rank of Iran to date. Overall, 67744 articles have been produced in 2019, showing a 13% growth, compared to 2018.